NVO240906C136000
- 2.14
- -2.36-52.44%
Novo-Nordisk A/S Newsroom
Novo Nordisk's Says Ozempic Shortage Deteriorates. Why It's Good News For Eli Lilly.
Novo Nordisk Warns of Continued Ozempic Shortage in Q4
Can the "weight loss miracle drug" from Novo Nordisk reduce the mortality rate of COVID-19 and bring more surprises?
The latest research found that people who took semaglutide have a 33% lower risk of death after being infected with COVID-19 compared to those who did not take it; Semaglutide not only reduces the risk of heart disease, but also has other benefits, such as improving symptoms of heart failure, inflammation, and reducing the mortality rate of patients with chronic kidney disease.
Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate
Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential
Weight-Loss Drugs' Promise And Pitfalls -- Barron's
Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits
Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients
Novo Highlights Heart Benefits of Weight Loss Drug With New Analysis
Express News | Novo Nordisk Says New Pooled Analysis Published In The Lancet Demonstrated Reduced Risk Of Combined CV Death Or Worsening Heart Failure With Semaglutide - Analysis Conducted Among 3,743 Patients With History Of Heart Failure
European stock markets are expected to close at record highs for the first time since May.
European stock markets are reclaiming lost ground from the summer and are expected to close at record highs for the first time since May, as strong economic data eases concerns about U.S. recession and investors bet on a Fed rate cut. The benchmark Stoxx Europe 600 index briefly rose 0.8% to 524.75 points, above the May closing high of 524.71 points, still below the intraday high of 525.59 reached in June. Danish pharmaceutical company Novo Nordisk, Dutch chip equipment company ASML, German software company SAP, and British pharmaceutical company AstraZeneca contributed to over a quarter of the index's gains this year. Danish pharmaceutical company Zealand.
New Medicare Drug Price Caps Could Help Seniors Save Over $1,000 a Year - AARP
AI Gold Rush Is Just Beginning. Why Nvidia, AMD, and Co. Can Ride It.
Danish police: The fire at novo-nordisk (NVO.US) in Kalundborg is not related to crime.
Local police chief Per Severs said that the authorities were unable to determine the exact cause of the fire at the Novo Nordisk Kalundborg factory on May 16th.
Biden Commends Eli Lilly for Cheaper Zepbound Version, Vows to Negotiate Lower Obesity Drug Prices
After the launch of the "Zepbound" in small bottles by Eli Lilly and Co, the stock price of Hims & Hers (HIMS.US), which gained popularity with its generic version of weight loss drugs, plummeted.
On Tuesday, Eli Lilly and Co announced the launch of a cheaper version of its popular weight loss drug Zepbound, followed by a sharp drop in the stock price of Hims & Hers Health.
Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker
Is the weight loss drug "Kaijuan"? Eli Lilly is selling Zepbound small bottles at a 50% discount.
It may have a positive impact on the sales of Eli Lilly and Co.
Medicare Coverage of Novo Nordisk's Wegovy Could Cost up to $145B Annually
Looking At Novo Nordisk's Recent Unusual Options Activity